Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06367582Recruiting

Spine Bone Cements Outcomes - Post Market Follow-up

Role: lead

NCT06374342Recruiting

Bone Substitutes Outcomes - Post Market Follow-up

Role: lead

NCT06532929Recruiting

Sport Surgery Products Outcomes - A Post-market Follow-up

Role: lead

NCT06354543Recruiting

Arthroplasty Cements Outcomes - A Post-market Follow-up

Role: lead

All 4 trials loaded